Multifunctional Lithium–Calcium–Silicon Bioceramic Resin Composite for Enhanced Dental Remineralization and Reparative Dentin Formation
Advanced Healthcare Materials · 2025-11 · 14 (30)
DOI: 10.1002/adhm.202500530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.08.2025. Verfasst von Peng Mei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao…. Hauptthemen laut MEDLINE: Dentin, Silicon, Tooth Remineralization, Lithium. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Deep carious lesions can progressively demineralize dentin and approach the pulp chamber, risking pulp exposure. Indirect pulp capping seeks to preserve remaining dentin and induce reparative dentin formation to protect the pulp and avoid root canal therapy. However, conventional pulp‐capping materials often lack sustained remineralization and sufficient dentinogenic induction. In this study, lithium calcium silicate (Li 2 Ca 4 Si 4 O 13 ) resin composite (RC) is designed to enhance dentin remineralization, stimulate reparative dentinogenesis, and provide anti‐inflammatory activity. In oral conditions, the RC steadily released lithium, calcium, and silicon ions. In vitro, the extract of RC increases alkaline phosphatase activity, promotes mineral nodule formation, and upregulates odontogenic genes ( DSPP , DMP1 , MEPE ) in dental pulp stem cells, while reducing the expression of Il‐1β , Tnf‐α , and Il‐4 of neutrophils. Demineralized dentin treated with the RC shows remineralization after 21 days in rat oral environment. Rat dentin exposure model shows that indirect pulp capping with RC generates more robust reparative dentin formation than iRoot BP. These findings demonstrate that the RC is a novel bioactive material combining effective remineralization, dentinogenic, and immunomodulatory properties, with strong potential for advanced dental remineralization and indirect pulp‐capping therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center of Stomatology, National Clinical Re…
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, China.
- Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, China.
ORCID-Profile: Bing Fang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Mei, P., Tao, X., Ding, Z., Li, R., Zhu, Z., Liu, C., Wang, R., Xia, L., Huan, Z., & Fang, B. (2025). Multifunctional Lithium–Calcium–Silicon Bioceramic Resin Composite for Enhanced Dental Remineralization and Reparative Dentin Formation. Advanced Healthcare Materials, 14(30). https://doi.org/10.1002/adhm.202500530
Vancouver
Mei P, Tao X, Ding Z, Li R, Zhu Z, Liu C, et al. Multifunctional Lithium–Calcium–Silicon Bioceramic Resin Composite for Enhanced Dental Remineralization and Reparative Dentin Formation. Advanced Healthcare Materials. 2025;14(30). doi:10.1002/adhm.202500530
BibTeX
@article{Mei2025,
author = {Mei, Peng and Tao, Xingyu and Ding, Ziduan and Li, Ruomei and Zhu, Zhiyu and Liu, Chenxiao and Wang, Ruiqing and Xia, Lunguo and Huan, Zhiguang and Fang, Bing},
title = {Multifunctional Lithium–Calcium–Silicon Bioceramic Resin Composite for Enhanced Dental Remineralization and Reparative Dentin Formation},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {30},
doi = {10.1002/adhm.202500530}
}
EUVIMED